Skip to main content
Premium Trial:

Request an Annual Quote

SpectronRx Coronavirus Test Gets FDA Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Friday granted Emergency Use Authorization for SpectronRx's Hymon SARS-CoV-2 Test Kit.

According to the Indianapolis-based company, the test kit is designed to detect regions of the virus' nucleocapsid and envelope genes in upper respiratory specimens and bronchoalveolar lavage. It runs on Thermo Fisher Scientific's Applied Biosystems 7500 RT-PCR system.

Use of the test is limited to laboratories CLIA-certified to perform high-complexity tests, the FDA said.

The kit is manufactured by Suzhou, China-based HymonBio.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.